Efficacy of inpatient treatment for atopic dermatitis evaluated by changes in serum cortisol levels

Journal of Dermatology

Volumn 40, Issue 1, 2013, Pages 43-47

  Fukuda, Hidetsugu ^a   Suzuki, Taku ^a   Saotome, Atsuko ^a   Sode, Eri ^a   Mukai, Hideki ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

atopic dermatitis; inpatient treatment; serum cortisol level; topical steroids; urinary free cortisol

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; LACTATE DEHYDROGENASE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CCL17 PROTEIN, HUMAN; DERMATOLOGICAL AGENT;

ARTICLE; ATOPIC DERMATITIS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CORTICOTROPIN BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; RHYTHM; SLEEP DISORDER; THERAPY EFFECT; ADULT; BLOOD; DERMATITIS, ATOPIC; HOSPITAL PATIENT; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADRENOCORTICOTROPIC HORMONE; ADULT; CHEMOKINE CCL17; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; FEMALE; HUMANS; HYDROCORTISONE; INPATIENTS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872487578     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2012.01678.x     Document Type: Article

References (14)

1. Fukuda H, Suzuki T, Sato Y, Saruya K, Mukai H,. Usefulness of inpatient treatment for severe atopic dermatitis demonstrated by evaluation of changes in serum cortisol levels. Jpn J Dermatol 2010; 120: 2195-2201. (In Japanese.)
2. Furue M, Saeki H, Furukawa F, et al,. Guidelines for management of atopic dermatitis. Jpn J Dermatol 2009; 119: 1515-1534. (In Japanese.)
3. Saeki H, Furue M, Furukawa F, et al,. Guideline for management of atopic dermatitis. J Dermatol 2009; 36: 563-577.
4. Kaneko S, Mukuno A, Aiba S, Mukai H,. Early intervention by the hospitalization treatment of severe atopic dermatitis. Skin Re 2008; 7 (Suppl): 70-75. (In Japanese.)
5. Haeck IM, Mik LT, Lentjes EGWM, et al,. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused. Br J Dermatol 2007; 156: 979-985.
6. Mukai H, Noguchi T, Kamimura K, Nishioka K, Nishiyama S,. Significance of high serum LDH (lactate dehydrogenase) activity in atopic dermatitis. Jpn J Dermatol 1987; 97: 1623-1629. (In Japanese.)
7. Shimao S,. Problems regarding side effects of corticosteroid therapy in the field of dermatology. Nishinihon J Dermatol 1978; 40: 5-24. (In Japanese.)
8. Munro DD,. The effect of percutaneously absorbed steroids on hypothalamic-pituitary-adrenal function after intensive use in in-patients. Br J Dermatol 1976; 94: 67-76.
9. Heubeck B, Schonberger A, Hornstein OP,. Sind verschiebungen des zirkadianen cortisolrhythmus ein endokrines symptom des atopischen ekzems?. Hautarzt 1988; 39: 12-17.
10. Slominski AT, Botchkarev V, Choudhry M, et al,. Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?" Ann NY Acad Sci 1999; 885: 287-311.
11. Vukelic S, Stojadinovic O, Pastar I, et al,. Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. J Biol Chem 2011; 286: 10265-10275.
12. Verhoeven EWM, Kraaimaat FW, van de Kerkhof PCM, et al,. Stress and psoriasis: a prospective study. J Invest Dermatol 2009; 129: 2075-2077.
13. Verhoeven EWM, Kraaimaat FW, de Jong EMGJ, et al,. Individual differences for stress reactivity in psoriasis: a prospective study. Br J Dermatol 2009; 161: 295-299.
14. Evers AWM, Verhoeven EWM, Kraaimaat FW, et al,. How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol 2010; 163: 986-991.